Lilly Testing New Antibody for South Africa Coronavirus Variant, Says Company Executive
Eli Lilly will move a new COVID-19 antibody therapy to human trials targeting a coronavirus variant that was first found in South Africa, the US drugmaker said on Tuesday. Reuters Health Information